Although a potentially preventable disease, cervical cancer (CC) is the second most
commonly diagnosed gynaecological cancer with at least 530,000 new cases annually, and …

Cervical cancer (CC) is a common malignancy in women and a major cause of cancer‐
related mortality globally. Some novel biomarkers may enable the early diagnosis and …

Cervical cancer (CC) is the third most diagnosed cancer among females worldwide and the
fourth cause of cancer-related mortality. Prophylactic HPV vaccines and traditional pap …

Purpose: MicroRNAs (miRNA) are small noncoding RNAs that are 18 to 25 nucleotides in
length; they regulate the stability or translational efficiency of target mRNAs. Emerging …

MicroRNAs (miRNAs) are a class of small non coding RNAs of 18–25 nucleotides in length.
The temporal or short‐lived expression of the miRNAs modulates gene expression post …

Cervical cancer (CC) is one of the leading causes of death in women due to cancer and a
major concern in the developing world. Persistent human papilloma virus (HPV) infection is …

MicroRNAs (miRNAs) are short regulatory RNAs that modulate the transcriptome and
proteome at the post‐transcriptional level. To obtain a better understanding on the role of …

Because altered microRNAs (miRNAs) expression patterns have been observed in a variety
of diseased tissues, miRNA expression was compared in human cervical cancer tissues …

Purpose MicroRNAs (miRNAs) exhibit dysregulated expression in human cancer and play
an important role in carcinogenesis. The aim of this study was to identify a distinct miRNA …

MicroRNAs (miRNAs) are a recently discovered family of 18–24 nucleotide non-coding
RNAs that can negatively regulate target mRNAs. All studied multicellular eukaryotes utilize …